Edwards Lifesciences
EW
C$104.46
Share price
-0.30%
Change (1 day)
-17.04%
Change (1 year)
Categories
Edwards Lifesciences (EW) - Total debt
Total debt on the balance sheet as of March 2025 : C$0.95 Billion
According to Edwards Lifesciences's latest financial reports the company's total debt is C$0.95 Billion. A company’s total debt is the sum of all current and non-current debts.
Edwards Lifesciences - Total debt on balance sheet (from 2000 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | C$1.00 B | 10.54% |
| 2023-12-31 | C$0.90 B | -3.13% |
| 2022-12-31 | C$0.93 B | 6.63% |
| 2021-12-31 | C$0.87 B | -0.71% |
| 2020-12-31 | C$0.88 B | -0.06% |
| 2019-12-31 | C$0.88 B | 9.6% |
| 2018-12-31 | C$0.80 B | -37.92% |
| 2017-12-31 | C$1.30 B | 17.91% |
| 2016-12-31 | C$1.10 B | 33.46% |
| 2015-12-31 | C$0.82 B | 19.3% |
| 2014-12-31 | C$0.69 B | 9.94% |
| 2013-12-31 | C$0.63 B | 235.4% |
| 2012-12-31 | C$0.18 B | 23.04% |
| 2011-12-31 | C$0.15 B | 266.14% |
| 2010-12-31 | C$41.78 M | -56.02% |
| 2009-12-31 | C$95.01 M | -55.47% |
| 2008-12-31 | C$0.21 B | 1.04% |
| 2007-12-31 | C$0.21 B | -23.11% |
| 2006-12-31 | C$0.27 B | -25.37% |
| 2005-12-31 | C$0.36 B | 14.71% |
| 2004-12-31 | C$0.32 B | -3.32% |
| 2003-12-31 | C$0.33 B | -14.42% |
| 2002-12-31 | C$0.38 B | -21.71% |
| 2001-12-31 | C$0.49 B | -22.76% |
| 2000-12-31 | C$0.64 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | C$15.92 B | 1,574.01% | 🇺🇸 USA |
 Merit Medical MMSI | C$1.11 B | 16.91% | 🇺🇸 USA |
 LeMaitre Vascular LMAT | C$0.25 B | -73.50% | 🇺🇸 USA |
 CryoLife CRY | N/A | N/A | 🇺🇸 USA |
 Medtronic MDT | C$36.19 B | 3,704.26% | 🇮🇪 Ireland |
 ICU Medical
ICUI | C$2.17 B | 128.83% | 🇺🇸 USA |